Burning Mouth Syndrome: Symptoms and Management
ConditionBurning Mouth Syndrome
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Massachusetts, Amherst
About this trial
This research study aims to evaluate how an oral cooling spray, currently a commercial dietary supplement, impacts symptoms associated with burning mouth syndrome (BMS). This study will examine symptoms, frequency, and severity, along with other related side effects of BMS on food intake, enjoyment, and quality of life.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Have buring mouth syndrome or experience oral burn
Live in the United States
At least 18 years old
Having been diagnosed or suspected diagnosis of burning mouth syndrome or suffer from chronic oral burn without any identifiable causative lesion
Disqualifiers
Have recently undergone dental treatment in the last three months or have plans to undergo dental treatment (e.g., fillings, crowns, root canals, extractions, or other dental procedures) in the coming month.
Have started any new treatments for BMS in the last 3 months or have plans to start new treatments in the coming month.
Trial design
Design model
Single group
Treatments tested in this trial
Oral cooling spray
Dietary supplementUse oral spray 3 times per day for 2 weeks
Treatment groups
50 Participants
are divided into 1 treatment groupGroup A: Oral sprayExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Improved symptoms
Frequency, severity, and duration of oral burn between regular treatment decreases after 2 weeks of using the oral spray
Time frame
2 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov